News | Cardiac Imaging | June 15, 2023

Dr. Jonathan Weinsaft Named Chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center

Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and cardiovascular imaging, has been appointed chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.

Dr. Jonathan Weinsaft, image courtesy of Weill Cornell Medicine 


June 15, 2023 — Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and cardiovascular imaging, has been appointed chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1. 

The Greenberg Division of Cardiology, housed within the Weill Department of Medicine, is dedicated to diagnosing and treating patients with disorders of the heart and blood vessels that comprise the cardiovascular system. 

In his new role, Dr. Weinsaft will further strengthen the division as a leader in scientific and technological innovation in cardiology, growing its research programs and translating these findings into exceptional patient care. He will also prioritize the training and mentoring of the next generation of junior faculty and fellows specializing in cardiovascular conditions and work to strengthen cardiovascular collaborations across NewYork-Presbyterian campuses affiliated with Weill Cornell Medicine. 

“Dr. Weinsaft is an outstanding physician-scientist, a leader in his field and a dedicated mentor,” said Dr. John Leonard, interim chair of the Weill Department of Medicine and interim physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center. “He is an ideal choice for guiding the Greenberg Division of Cardiology’s next chapter. I look forward to working with him as we continue to advance our efforts in research and patient care through collaboration with our experts in cardiology and related disciplines across our academic medical center.” 

Dr. Weinsaft, who joined Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center in 2005, is currently the Antonio M. Gotto Jr., M.D. Professor in Atherosclerosis and Lipid Research and a professor of medicine and of medicine in radiology. He also serves as director of the non-invasive cardiac imaging program at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center. 

Dr. Weinsaft succeeds Dr. Bruce Lerman, who has led the division since 1995 and will remain on Weill Cornell Medicine’s faculty. Dr. Lerman will lead the Greenberg Institute for Cardiac Electrophysiology, where he will continue his clinical care and research activities. 

Dr. Weinsaft is an expert in an array of cardiac imaging modalities, including technical development and clinical applications. He has held leadership positions in multiple cardiology programs over the last two decades, including cardiac MRI and nuclear cardiology programs that span Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, other Weill Cornell Medicine-affiliated NewYork-Presbyterian campuses, and Memorial Sloan Kettering Cancer Center. 

“I’m excited and humbled to take on this unique opportunity to lead our world-class cardiology division, especially as Weill Cornell Medicine and NewYork-Presbyterian have been central to my career since the beginning,” Dr. Weinsaft said. “Working with our faculty, trainees and staff who are all focused on excellence is an honor and a privilege.” 

As division chief, Dr. Weinsaft will collaborate with colleagues in related divisions and departments, recognizing that patients with cardiovascular diseases are treated by multidisciplinary experts in cardiology and cardiac surgery. “By fostering teamwork and collaboration between cardiovascular disciplines and among our affiliated campuses, I look forward to leading the continued growth of our clinical, research and educational programs, which are intrinsically linked and focused on improving patients’ outcomes,” he said. 

 

About Dr. Jonathan Weinsaft 

Dr. Weinsaft is a physician-scientist with over a decade-long track record of continuous extramural research support as provided by the National Institutes of Health and other agencies. He has served as principal or co-principal investigator for funded studies investigating new methods to measure blood oxygen saturation in patients with heart failure; diseases of the heart valves and how the valves respond to therapies; and understanding how the major heart artery, the aorta, responds to surgical graft replacement. He is also developing an NIH-funded training program to provide mentorship and training in basic and translational clinical cardiovascular research to trainees at Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and The Rockefeller University. 

Dr. Weinsaft has authored more than 140 articles and mentored more than 100 trainees who have authored manuscripts published in leading, peer-reviewed journals. He has served in editorial positions for journals including Circulation: Cardiovascular Imaging and the Journal of the American College of Cardiology: Cardiovascular Imaging. In addition, Dr. Weinsaft has served on NIH study sections and expert consensus panels for many cardiovascular conditions. He is a member of the American Heart Association, the American College of Cardiology, the Society for Cardiac Magnetic Resonance and the National Marfan Foundation Scientific Advisory Board. An expert in his field, Dr. Weinsaft is a frequently invited speaker at leading medical institutions nationally and internationally.  

Dr. Weinsaft received his bachelor’s, master’s and medical degrees from New York University. He completed an internal medicine residency and a cardiology fellowship at NewYork-Presbyterian/Weill Cornell Medical Center, followed by a fellowship in cardiac imaging at Duke University Medical Center. He then returned to Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, where he has served on faculty since 2005. Dr. Weinsaft holds adjunct clinical and faculty appointments at NewYork-Presbyterian Queens and Memorial Sloan Kettering Cancer Center, respectively, in conjunction with integrated program development initiatives. 

For more information: https://weill.cornell.edu/


Related Content

News | Cardiovascular Business

April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...

Home April 09, 2024
Home
News | Cardiovascular Business

April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit ...

Home April 05, 2024
Home
News | Cardiovascular Business

April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...

Home April 05, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is a Top 10 look at the content that was trending during the month of March on dicardiology.com: 1. CLS Health ...

Home April 04, 2024
Home
News | Cardiovascular Business

March 19, 2024 — The American College of Cardiology (ACC) has selected 50 learners for its 2024 – 2025 Clinical Trials ...

Home March 19, 2024
Home
News | Cardiovascular Business

March 19, 2024 — Titan Medical Inc. announced that it has entered into a definitive amalgamation agreement (the ...

Home March 19, 2024
Home
News | Cardiovascular Business

March 15, 2024 —Renowned cardiovascular surgeon Gilbert H. L. Tang, MD, has been named Editor-in-Chief of JACC: Case ...

Home March 15, 2024
Home
News | Cardiovascular Business

March 15, 2024 —Renowned cardiovascular surgeon Gilbert H. L. Tang, MD, has been named Editor-in-Chief of JACC: Case ...

Home March 15, 2024
Home
News | Cardiovascular Business

March 13, 2024 — Two nationally recognized cardiovascular programs, New Jersey-based Atlantic Health System’s Morristown ...

Home March 13, 2024
Home
News | Cardiovascular Business

March 11, 2024 — VahatiCor, Inc., a med tech company dedicated to helping patients with persistent ischemic heart ...

Home March 11, 2024
Home
Subscribe Now